BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 809441)

  • 1. Metabolism of neutral glycosphingolipids in plasma of a normal human and a patient with Fabry's disease.
    Vance DE; Krivit W; Sweeley CC
    J Biol Chem; 1975 Oct; 250(20):8119-25. PubMed ID: 809441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of immobilized fig alpha-galactosidase and effect on ceramide-3 content of plasma from patients with Fabry's disease.
    Schram AW; Hamers MN; Oldenbroek-Haverkamp E; Strijland A; de Jonge A; van den Bergh FA; Tager JM
    Biochim Biophys Acta; 1978 Dec; 527(2):456-64. PubMed ID: 31916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral glycosphingolipids of serum lipoproteins in Fabry's disease.
    Clarke JT; Stoltz JM; Mulcahey MR
    Biochim Biophys Acta; 1976 May; 431(2):317-25. PubMed ID: 181056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neutral glycosphingolipids of Fabry's disease lymphoblastoid lines established by Epstein-Barr virus transformation].
    Salvayre R; Maret A; Negre A; Douste-Blazy L
    Eur J Biochem; 1985 Feb; 147(1):77-82. PubMed ID: 2982612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on glycosphingolipid biosynthesis by lectin-stimulated human lymphocytes.
    Vakirtzi-Lemonias C; Evangelatos GP; Kapoulas VM; Levis GM
    Eur J Biochem; 1980 Aug; 109(2):541-51. PubMed ID: 7408900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in glycosphingolipid patterns in a line of African green monkey kidney cells infected with herpesvirus.
    Schroder EW; Merrick JM
    J Virol; 1979 Dec; 32(3):734-40. PubMed ID: 229262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of plasma low density lipoprotein with abnormal glycolipid composition from patients with Fabry's disease.
    Clarke JT; Stoltz JM; Garner JB
    Atherosclerosis; 1980 Feb; 35(2):155-63. PubMed ID: 6766308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of plasma neutral glycosphingolipids by high performance liquid chromatography of their perbenzoyl derivatives.
    Ullman MD; McCluer RH
    J Lipid Res; 1977 May; 18(3):371-8. PubMed ID: 405444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glycosphingolipids of human plasma lipoproteins.
    Clarke JT
    Can J Biochem; 1981 Jun; 59(6):412-7. PubMed ID: 6794884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of neutral glycosphingolipids in human plasma.
    van den Bergh FA; Tager JM
    Biochim Biophys Acta; 1976 Sep; 441(3):391-402. PubMed ID: 184824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B.C.P. Jansen Institute, University of Amsterdam, Amsterdam, The Netherlands.
    Van den Bergh FA; Rietra PJ; Kolk-Vegter AJ; Bosch E; Tager JM
    Acta Med Scand; 1976; 200(4):249-56. PubMed ID: 824932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased urinary excretion of glycosphingolipids in familial hypercholesterolemia.
    Chatterjee S; Sekerke CS; Kwiterovich PO
    J Lipid Res; 1982 May; 23(4):513-22. PubMed ID: 6808069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures and fatty acid compositions of neutral glycosphingolipids of human plasma.
    Kościelak J; Maśliński W; Zieleński J; Zdebska E; Brudzyński T; Miller-Podraza H; Cedergren B
    Biochim Biophys Acta; 1978 Sep; 530(3):385-93. PubMed ID: 698239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabry's disease.
    Adam T; Alexandrescu L; Voinea F; Toringhibel M; Hâncu A
    Rom J Intern Med; 2006; 44(4):455-64. PubMed ID: 18386622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical diagnosis of Fabry's disease by fluorometric assay and fast atom bombardment/mass spectrometry.
    Nakanishi T; Funahashi S; Funai T; Hashimoto T; Shimizu A
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():368-72. PubMed ID: 1654042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation kinetics of subpopulations of human marrow cells determined by quantifying in vivo incorporation of [2H2]-glucose into DNA of S-phase cells.
    Schwartz GN; Vance BA; Levine BM; Fukazawa M; Telford WG; Cesar D; Hellerstein M; Gress RE
    Blood; 2003 Sep; 102(6):2068-73. PubMed ID: 12763933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabry's disease with partially deficient hydrolysis of ceramide trihexoside.
    Kobayashi T; Kira J; Shinnoh N; Goto I; Kuroiwa Y
    J Neurol Sci; 1985 Feb; 67(2):179-85. PubMed ID: 2984338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytolipin R from rat spleen.
    Arita H; Kawanami J
    J Biochem; 1977 Jun; 81(6):1661-4. PubMed ID: 893368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemistry of the Lewis blood-group system: isolation and structures of Lewis-c active and related glycosphingolipids from the plasma of blood-group O Le(a-b-) nonsecretors.
    Hanfland P; Kordowicz M; Peter-Katalinic J; Pfannschmidt G; Crawford RJ; Graham HA; Egge H
    Arch Biochem Biophys; 1986 May; 246(2):655-72. PubMed ID: 2423032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of ceramide trihexoside in cultured skin fibroblasts from Fabry's patients, carriers and normal controls.
    Kobayashi T; Shinnoh N; Kuroiwa Y
    J Neurol Sci; 1984 Aug; 65(2):169-77. PubMed ID: 6090593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.